Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Urso

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Seminars in Nuclear Medicine|January 13, 2024
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's HealthLaura Evangelista, Priscilla Guglielmo, Agata Pietrzak, et al.
Expert Review of Molecular Diagnostics|November 27, 2023
Molecular imaging of PARP in cancer: state-of-the-artLuca Filippi, Luca Urso, Viviana Frantellizzi, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|February 23, 2024
Cavernous Hepatic Hemangioma at 18F-Choline Positron Emission Tomography-Computed Tomography: Be Aware of the PitfallAnna Margherita Maffione, Luca Urso, Modonesi Caterina, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|June 16, 2023
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case reportAlberto Nieri, Luca Urso, Matteo Caracciolo, et al.
Diagnostics (Basel, Switzerland)|December 22, 2023
Diagnostic Accuracy of PET with <sup>18</sup>F-Fluciclovine ([<sup>18</sup>F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-AnalysisAngelo Castello, Domenico Albano, Barbara Muoio, et al.
Cancers|June 22, 2023
<sup>18</sup>F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant ChemotherapyNatale Quartuccio, Pierpaolo Alongi, Luca Urso, et al.
Seminars in Nuclear Medicine|November 30, 2025
The Value of FDG PET/CT in Penile Cancer: An UpdateIlham Badrane, Alberto Nieri, Domenico Albano, et al.
Nuclear Medicine and Molecular Imaging|November 20, 2023
<sup>68</sup>Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade TumorsLuca Urso, Giovanni Christian Rocca, Grazia Maria Conti, et al.
Nuclear Medicine Communications|January 13, 2022
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancerLuca Urso, Natale Quartuccio, Matteo Caracciolo, et al.
Molecular Diagnosis & Therapy|March 11, 2026
Colorectal Cancer: A Landscape of New Potential RadiopharmaceuticalsVeronica Serena Cabitza, Pier Cesare Capponi, Irene Brusa, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Seminars in Nuclear Medicine|January 13, 2024
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's HealthLaura Evangelista, Priscilla Guglielmo, Agata Pietrzak, et al.
Expert Review of Molecular Diagnostics|November 27, 2023
Molecular imaging of PARP in cancer: state-of-the-artLuca Filippi, Luca Urso, Viviana Frantellizzi, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|February 23, 2024
Cavernous Hepatic Hemangioma at 18F-Choline Positron Emission Tomography-Computed Tomography: Be Aware of the PitfallAnna Margherita Maffione, Luca Urso, Modonesi Caterina, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|June 16, 2023
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case reportAlberto Nieri, Luca Urso, Matteo Caracciolo, et al.
Diagnostics (Basel, Switzerland)|December 22, 2023
Diagnostic Accuracy of PET with <sup>18</sup>F-Fluciclovine ([<sup>18</sup>F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-AnalysisAngelo Castello, Domenico Albano, Barbara Muoio, et al.
Cancers|June 22, 2023
<sup>18</sup>F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant ChemotherapyNatale Quartuccio, Pierpaolo Alongi, Luca Urso, et al.
Seminars in Nuclear Medicine|November 30, 2025
The Value of FDG PET/CT in Penile Cancer: An UpdateIlham Badrane, Alberto Nieri, Domenico Albano, et al.
Nuclear Medicine and Molecular Imaging|November 20, 2023
<sup>68</sup>Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade TumorsLuca Urso, Giovanni Christian Rocca, Grazia Maria Conti, et al.
Nuclear Medicine Communications|January 13, 2022
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancerLuca Urso, Natale Quartuccio, Matteo Caracciolo, et al.
Molecular Diagnosis & Therapy|March 11, 2026
Colorectal Cancer: A Landscape of New Potential RadiopharmaceuticalsVeronica Serena Cabitza, Pier Cesare Capponi, Irene Brusa, et al.
Pageof 10